Back to Search
ERIC COHEN, M.D.
M.D.
Child & Adolescent Psychiatry Physician
NPI: 1619991700Individual
Specialties, Licenses & Credentials
Child & Adolescent Psychiatry PhysicianPrimary
Psychiatry & Neurology — Child & Adolescent Psychiatry
Code: 2084P0804X
029965(CT)
Research & Publications (20)
A golden anniversary: fifty years of child and adolescent psychiatry at the Institute of Living.
PMID 16270795·Conn Med·2005
8-other
Efficacy and safety of treating T4 oral cavity tumors with primary chemoradiotherapy.
PMID 19340870·Head Neck·2009
8-other
Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study.
PMID 19201650·Lancet Oncol·2009
3-trial
A feed-forward loop involving protein kinase Calpha and microRNAs regulates tumor cell cycle.
PMID 19117988·Cancer Res·2009
7-preclinical
Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: results from a phase II study.
PMID 18541897·J Clin Oncol·2008
3-trial
A disturbance in the force--mitochondrial mutations in squamous cell carcinoma of the head and neck.
PMID 17671110·Clin Cancer Res·2007
8-other
Phase I trial of tirapazamine, cisplatin, and concurrent accelerated boost reirradiation in patients with recurrent head and neck cancer.
PMID 17293229·Int J Radiat Oncol Biol Phys·2007
3-trial
Alcohol treatment utilization: findings from the National Epidemiologic Survey on Alcohol and Related Conditions.
PMID 16919401·Drug Alcohol Depend·2007
8-other
High survival and organ function rates after primary chemoradiotherapy for intermediate-stage squamous cell carcinoma of the head and neck treated in a multicenter phase II trial.
PMID 16849759·J Clin Oncol·2006
3-trial
Protein kinase C zeta mediates epidermal growth factor-induced growth of head and neck tumor cells by regulating mitogen-activated protein kinase.
PMID 16778206·Cancer Res·2006
8-other
Role of epidermal growth factor receptor pathway-targeted therapy in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.
PMID 16763280·J Clin Oncol·2006
6-review
Phase II trial of gefitinib 250 mg daily in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.
PMID 16322304·Clin Cancer Res·2005
3-trial
Novel therapeutic targets in squamous cell carcinoma of the head and neck.
PMID 15599853·Semin Oncol·2004
6-review
The expanding role of systemic therapy in head and neck cancer.
PMID 15117998·J Clin Oncol·2004
6-review
Induction chemotherapy and radiotherapy in locally advanced non-small cell lung cancer.
PMID 15005282·Hematol Oncol Clin North Am·2004
6-review
Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck.
PMID 12743152·J Clin Oncol·2003
3-trial
Adenosine deaminase inhibition attenuates microvascular dysfunction and improves survival in sepsis.
PMID 12091165·Am J Respir Crit Care Med·2002
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 200 RETREAT AVENUE, HARTFORD HOSPITAL ADULT PSYCHIATRY
HARTFORD, CT 06106 - Phone
- (860) 545-7493
Quick Facts
- NPI
- 1619991700
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile